The LR3 (Long R3) modification is a clever bit of bioengineering that dramatically extends its half-life and, crucially, prevents it from being bound and rendered inactive by insulin-like growth factor-binding proteins (IGFBPs) in the bloodstream
Cigna Groups health services unit Evernorth announced a new one-year program, EncircleRx, at its Investor Day on March 7th, 2024, that is aimed at helping employers manage the costs of these drugs
This is the Peptide Depot team happy to help
Available as an IM injection for localized effects or as an IV infusion for full-body benefits
These models permit the testing not only of thyroid hormone replacement but also act as a vehicle to test putative interventions for developmental deficits due to thyroid hormone insufficiency (Kim et al
Medications were delivered quickly and packaged with care